Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Aortic Stent and Vascular Graft devices include Aortic Stent Grafts, Vascular Grafts and Extenders. Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. GlobalData uses proprietary data and analytics to provide a comprehensive report on the vascular grafts market in Greece. Buy the latest report here.

Smarter leaders trust GlobalData

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Vascular Grafts are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta. Vascular grafts are classified into autografts, allografts and synthetic vascular grafts on the basis of the materials. Autograft vascular grafts are vascular grafts taken from the individual and used in the same individual. These grafts are not tracked in this market. Allograft vascular grafts are vascular grafts taken from another individual and used in the treated patient. Synthetic vascular grafts are the grafts which are manufactured using polymers. Polyester and Polytetrafluoroethylene (PTFE) are the two synthetic materials used to construct synthetic vascular grafts. Synthetic (polyethyleneterepthalate) vascular grafts are made from polymer yarn woven tubes whereas Synthetic PTFE vascular grafts are made by mechanically stretching sheets of polytetrafluoroethylene. Aortic vascular grafts are grafts that are used to replace and repair damaged portions of the aorta. Peripheral vascular grafts are grafts that are used to replace and repair damaged blood vessels outside of the aorta.

The vascular grafts market in Greece can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size vascular grafts in Greece, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.